Aggregator

Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets

3 months 2 weeks ago

Some manufacturers are now embedding CER processes within broader regulatory operating systems, integrating authoring, surveillance, and quality management to enable real-time adaptability. Artificial Intelligence (AI) , in particular, is playing an increasingly critical role in helping manufacturers meet expanding regulatory expectations.

The post Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets appeared first on MedTech Intelligence.

Rich West